Cargando…
Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL
Targeting BCL-2, a key regulator of survival in B-cell malignancies including precursor B-cell acute lymphoblastic leukemia, has become a promising treatment strategy. However, given the redundancy of anti-apoptotic BCL-2 family proteins (BCL-2, BCL-XL, MCL-1), single targeting may not be sufficient...
Autores principales: | Seyfried, Felix, Stirnweiß, Felix Uli, Niedermayer, Alexandra, Enzenmüller, Stefanie, Hörl, Rebecca Louise, Münch, Vera, Köhrer, Stefan, Debatin, Klaus-Michael, Meyer, Lüder Hinrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979822/ https://www.ncbi.nlm.nih.gov/pubmed/35031695 http://dx.doi.org/10.1038/s41375-021-01502-z |
Ejemplares similares
-
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling
por: Seyfried, Felix, et al.
Publicado: (2019) -
Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state
por: Trentin, Luca, et al.
Publicado: (2018) -
P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Sun, Qian, et al.
Publicado: (2023) -
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Manzano-Muñoz, Albert, et al.
Publicado: (2021) -
Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)